Xilio Therapeutics (XLO) Operating Income (QoQ) (2020 - 2026)
Xilio Therapeutics (XLO) Operating Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 472.86 Bn | 468.07 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.71 Bn | 116.47 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.61 Bn | 62.86 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.62 Bn | 49.44 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.09 Bn | 35.08 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.08 Bn | 36.08 Bn | - |
| 10 | Xilio Therapeutics | 146.88 Mn | -3.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.23% |
| Dec 31, 2025 | -513.58% |
| Sep 30, 2025 | 86.57% |
| Jun 30, 2025 | -3.72% |
| Mar 31, 2025 | -1.63% |
| Dec 31, 2024 | 7.68% |
| Sep 30, 2024 | -0.39% |
| Jun 30, 2024 | 15.91% |
| Mar 31, 2024 | 3.55% |
| Dec 31, 2023 | -4.43% |
| Sep 30, 2023 | 13.70% |
| Jun 30, 2023 | 14.49% |
| Mar 31, 2023 | -1.55% |
| Dec 31, 2022 | -14.65% |
| Sep 30, 2022 | 17.70% |
| Jun 30, 2022 | -15.68% |
| Mar 31, 2022 | -8.53% |
| Dec 31, 2021 | -22.52% |
| Sep 30, 2021 | 30.63% |
| Jun 30, 2021 | -39.27% |